Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Stelter

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Infection and Immunity|March 1, 1997
Specific binding of soluble peptidoglycan and muramyldipeptide to CD14 on human monocytesB Weidemann, J Schletter, R Dziarski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2000
Cutting edge: human B cell function is regulated by interaction with soluble CD14: opposite effects on IgG1 and IgE productionM A Arias, J E Rey Nores, N Vita, et al.
European Journal of Immunology|February 5, 1999
Soluble CD14 acts as a negative regulator of human T cell activation and functionJ E Rey Nores, A Bensussan, N Vita, et al.
Nature|October 24, 1997
Lipopolysaccharide-binding protein is required to combat a murine gram-negative bacterial infectionR S Jack, X Fan, M Bernheiden, et al.
Scientific Reports|August 19, 2025
ZEB1 stratifies the response to Sorafenib and Mdivi-1 combination therapy in hepatocellular carcinomaH Freudenstein, M Strecker, S Gylstorff, et al.
European Journal of Immunology|December 18, 2001
Lipopolysaccharide and ceramide docking to CD14 provokes ligand-specific receptor clustering in raftsA Pfeiffer, A Böttcher, E Orsó, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Infection and Immunity|March 1, 1997
Specific binding of soluble peptidoglycan and muramyldipeptide to CD14 on human monocytesB Weidemann, J Schletter, R Dziarski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2000
Cutting edge: human B cell function is regulated by interaction with soluble CD14: opposite effects on IgG1 and IgE productionM A Arias, J E Rey Nores, N Vita, et al.
European Journal of Immunology|February 5, 1999
Soluble CD14 acts as a negative regulator of human T cell activation and functionJ E Rey Nores, A Bensussan, N Vita, et al.
Nature|October 24, 1997
Lipopolysaccharide-binding protein is required to combat a murine gram-negative bacterial infectionR S Jack, X Fan, M Bernheiden, et al.
Scientific Reports|August 19, 2025
ZEB1 stratifies the response to Sorafenib and Mdivi-1 combination therapy in hepatocellular carcinomaH Freudenstein, M Strecker, S Gylstorff, et al.
European Journal of Immunology|December 18, 2001
Lipopolysaccharide and ceramide docking to CD14 provokes ligand-specific receptor clustering in raftsA Pfeiffer, A Böttcher, E Orsó, et al.
Pageof 3